Genetically modified bacillus subtilis strain and use as a live delivery and production system
US-2024390433-A1 · Nov 28, 2024 · US
Bifidobacteriumstrain
US9259019B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9259019-B2 |
| Application number | US-201213468512-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 10, 2012 |
| Priority date | Nov 11, 2010 |
| Publication date | Feb 16, 2016 |
| Grant date | Feb 16, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Bifidobacterium strain AH121A is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
First claim
Opening claim text (preview).
What is claimed is: 1. A formulation which comprises Bifidobacterium longum strain AH121A deposited with the NCIMB under accession number 41675; wherein the formulation further comprises an ingestible carrier, and wherein the ingestible carrier is a food product selected from the group consisting of an oil suspension, a milk-based suspension, cheese, a cocoa butter based composition, a gravy and a yogurt based composition. 2. The formulation of claim 1 ,…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9259019B2 cover?
- Bifidobacterium strain AH121A is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
- Who is the assignee on this patent?
- O'Mahony Liam, Kiely Barry, Mars Inc, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A23L33/135. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).